Marex Group’s NewGenIvf NIVF Stock Holding History

Marex Group’s Portfolio NIVF Stock Details NIVF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11	Closed	-$10.4K	–	1027
2025 Q2	$10.4K	Buy	+11	New	+$28.5K	﹤0.01%	631
2025 Q1	–	Hold	0	–	-$7.49K	–	878
2024 Q4	–	Hold	0	–	–	–	664

Other funds holding NIVF

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marex Group's NIVF Position: Q3 2025 in Review

Marex Group sold out of NewGenIvf (NIVF) in Q3 2025, closing a stake of 11 shares — an estimated $10.4K sold.

Marex Group first reported a position in NIVF in Q2 2025 and held it in 1 quarter. The position peaked at $10.4K in Q2 2025. 1 fund tracked by Wall St. Rank holds NIVF as of Q3 2025.

Marex Group reported no remaining NewGenIvf position as of Q3 2025 after selling out during the quarter.
Marex Group sold 11 NewGenIvf shares in Q3 2025, an estimated $10.4K.
Marex Group first reported a position in NewGenIvf in Q2 2025 and held it in 1 quarter.
Marex Group's NewGenIvf position peaked at $10.4K in Q2 2025.
1 fund tracked by Wall St. Rank held NewGenIvf as of Q3 2025.

Based on Marex Group's 13F filing for Q3 2025, filed 14 Nov 2025.